Literature DB >> 11891803

Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency.

C Cunningham-Rundles1, Dennis L Cooper, Thomas P Duffy, James Strauchen.   

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by low serum immunoglobulins IgG, IgA, and usually IgM. The central immune deficiency is impaired secretion of immunoglobulins and lack of antibody production; however, T cell dysfunction and a variety of inflammatory complications suggest global immune dysregulation. A number of reports have documented the association of primary immunodeficiency diseases with the development of non-Hodgkin's lymphoma (NHL). In CVID, the risk has been estimated to lie between 1.4% and 7%. As for NHL arising in other immunodeficiency states, the lymphomas in CVID are extranodal and are usually B cell in type. Of 22 B cell lymphomas that have appeared over a period of 25 years in a cohort of subjects with CVID, five lymphomas, appearing in more recently studied subjects, that arose in mucosal sites would be classified as mucosa-associated lymphoid tissue (MALT) lymphomas. MALT lymphomas are low-grade B cell lymphomas that result from a proliferation of neoplastic marginal-zone related cells of lymphoid tissue and tend to occur in organs that have acquired lymphoid tissue due to long-term infectious or autoimmune stimulation. Lymphomas of this kind have not been described in patients with congenital immunodeficiency, although chronic mucosal antigen stimulation is an integral part of these immune deficiency states.

Entities:  

Mesh:

Year:  2002        PMID: 11891803     DOI: 10.1002/ajh.10050

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  35 in total

Review 1.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

2.  Crohn's-like colitis in a patient with immunodeficiency associated with a defect in expression of inducible costimulator.

Authors:  Jonas Mudter; Stefan Wirtz; Benno Weigmann; Imke Tiede; Ingrid Tubbe; Ralf Kiesslich; Peter R Galle; Hans A Lehr; Markus F Neurath
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

Review 3.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

5.  A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID).

Authors:  Kaushang Gandhi; Purvi Parikh; Wilbert S Aronow; Harit Desai; Harshad Amin; Mala Sharma; Arye Rubinstein
Journal:  J Gastrointest Cancer       Date:  2010-12

Review 6.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 7.  Immunodeficiencies.

Authors:  M Ballow; L Notarangelo; B Grimbacher; C Cunningham-Rundles; M Stein; M Helbert; B Gathmann; G Kindle; A K Knight; H D Ochs; K Sullivan; J L Franco
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

8.  Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency.

Authors:  Monica Piquer Gibert; Laia Alsina; María Teresa Giner Muñoz; Ofelia Cruz Martínez; Karen Ruiz Echevarria; Olga Dominguez; Ana María Plaza Martín; Juan I Arostegui; Guillem de Valles; Manel Juan Otero; Maria Anunciacion Martin-Mateos
Journal:  Eur J Pediatr       Date:  2015-03-10       Impact factor: 3.183

Review 9.  [Primary CNS lymphoma in azathioprine therapy for autoimmune diseases: review of the literature and case report].

Authors:  F Kästner; W Paulus; M Deckert; P Schlegel; S Evers; I W Husstedt
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

Review 10.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.